FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanomaEva Skarmoutsou(University of Catania), Claudio Guarneri(University of Messina)International Journal of Molecular MedicineApril 4, 201810.3892/ijmm.2018.3618Cited by 17SaveCiteExport RISWatch citationsRelated PapersComparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)|Journal of Dermatological Treatment|2024|21